Cancer Biomedicine

The MSc in Cancer Biomedicine at University College London offers an in-depth exploration of the fundamental biological mechanisms underlying cancer development, progression, and treatment. This interdisciplinary programme is designed for students seeking to acquire advanced knowledge and practical skills in cancer research, opening pathways to careers in biomedical research, healthcare, and pharmaceutical industries. Throughout the course, students will engage with cutting-edge topics such as cancer genetics, molecular pathology, tumour immunology, and targeted therapies, supported by state-of-the-art laboratories and research facilities. The programme combines rigorous academic coursework with research project opportunities, allowing students to apply theoretical concepts to real-world scientific problems. Faculty members are renowned experts in oncology and biomedical sciences, providing mentorship and fostering an innovative learning environment. The curriculum is structured to develop competencies in experimental design, data analysis, and scientific communication, preparing graduates for doctoral research or employment in research institutions and biotech companies. Students will also benefit from seminars, workshops, and networking events with industry professionals, enhancing their understanding of the latest developments and career prospects in cancer biomedicine. With a strong emphasis on laboratory skills, critical thinking, and research ethics, the MSc aims to produce highly trained specialists capable of contributing to advancements in cancer diagnosis, treatment, and prevention. Graduates of this programme will be equipped to pursue doctoral studies, research roles, or careers in clinical settings, contributing to the fight against one of the most significant health challenges of our time. The programme is ideally suited for graduates with a background in biomedical sciences, medicine, or related disciplines who are passionate about contributing to cancer research and improving patient outcomes.

In each year of your degree you will take a number of individual modules, normally valued at 0.5 or 1.0 credits, adding up to a total of 4.0 credits for the year. Modules are assessed in the academic year in which they are taken. The balance of compulsory and optional modules varies from programme to programme and year to year. A 1.0 credit is considered equivalent to 15 credits in the European Credit Transfer System (ECTS).

Year one is demanding, covering the foundations of human biology and medicine. There are seven modules providing an understanding of human health and disease. Teaching of biochemistry, physiology and anatomy is integrated with an understanding of each organ system. One further module gives an introduction to cancer medicine in society and leads on to cancer-related modules in years two and three. You will be mostly based at UCL’s Royal Free campus in Hampstead, North London, and taught by world-leading scientists and clinicians.

Year two comprises six compulsory modules covering molecular biology, cancer biology and therapeutics, clinical cancer management and clinical trials. Two further modules are optional with a wide range of subjects to chose from including tissue engineering, behavioural science and pharmacology.

Year three comprises four compulsory and three optional modules, with the compulsory modules examining how new cancer treatment strategies are designed and tested. You will also undertake a research project. The wide range of optional modules allows students to tailor-make a preferred route within biomedical sciences, guided by interest and intended career choice.

A levels

Grades

AAA-AAB

Subjects

Biology and Chemistry required.

GCSEs

English Language and Mathematics at grade B. For UK-based students, a grade C or equivalent in a foreign language (other than Ancient Greek, Biblical Hebrew or Latin) is required. UCL provides opportunities to meet the foreign language requirement following enrolment, further details at: www.ucl.ac.uk/ug-reqs

IB Diploma

Points

36-38

Subjects

A total of 17-18 points in three higher level subjects including Biology and Chemistry, with no score below 5.

Funding options for the MSc in Cancer Biomedicine at University College London are diverse and designed to support a wide range of students, both domestic and international. Prospective students are encouraged to explore various sources of financial assistance to help fund their studies. The university offers a variety of scholarships, bursaries, and grants specifically aimed at postgraduate students. These may be awarded based on academic achievement, research interests, financial need, or a combination of these factors. It is recommended to regularly check the university’s official scholarships webpage for up-to-date information on available awards, application deadlines, and eligibility criteria.

In addition to university-specific funding, students can also explore external sources such as government-sponsored loans, private scholarships, and research council funding. For example, UK students may be eligible for loans through the Student Loans Company, which can be used to cover tuition fees and living expenses. International students should consider potential scholarships offered by their home governments or third-party organizations that support international study.

Research council funding, such as that from UK Research and Innovation (UKRI), may also be available for students engaged in biomedical research areas, including cancer studies. This type of funding typically requires a competitive application process and may include stipends for living expenses, research costs, and travel allowances.

Many students also seek partial funding through departmental teaching and research assistantships, which can provide additional income and practical experience. These positions are usually awarded based on academic merit and departmental needs and are highly competitive.

Students are advised to prepare comprehensive applications and to seek guidance from the university’s financial aid office, academic advisors, and faculty members involved in the Cancer Biomedicine program. Early planning and application are essential since many funding opportunities have strict deadlines.

Overall, financing a postgraduate degree at UCL involves multiple avenues, combining institutional support, external scholarships, government funding, and personal resources. Careful research, timely application, and proactive engagement will enhance students’ chances of securing adequate funding to support their academic and research pursuits in the field of Cancer Biomedicine.

Cancer Biomedicine at University College London is a comprehensive postgraduate program designed to provide students with an in-depth understanding of the molecular and cellular mechanisms underlying cancer development, progression, and treatment. The program combines core principles of biomedical sciences with specialized knowledge in oncology, equipping graduates with the skills needed for careers in cancer research, medicine, or healthcare industries. Delivered by leading experts in the field, the course includes lectures, workshops, and laboratory-based practicals that cover a wide range of topics such as molecular genetics, tumor biology, cancer therapeutics, immunology, and personalized medicine. Students will gain hands-on experience with state-of-the-art techniques and approaches used in current cancer research, fostering critical thinking and problem-solving skills essential for innovative research or clinical applications. The curriculum is designed to be flexible, offering elective modules that enable students to tailor their learning towards particular areas of interest within cancer biomedicine. Additionally, students have opportunities for research projects, often in collaboration with prominent research institutes affiliated with UCL, allowing for direct involvement in groundbreaking research initiatives. Graduates of the program are well-prepared for further research at doctoral level or for roles within the biomedical industries, hospitals, or research institutions. UCL’s strong links with medical and scientific communities provide a vibrant academic environment and networking opportunities, positioning students at the forefront of cancer research and treatment advancements. The program emphasizes multidisciplinary approaches, integrating knowledge from biology, medicine, chemistry, and physics to address complex cancer-related questions. Students will also learn about current challenges in translational research and innovative therapies in cancer care, preparing them to contribute meaningfully to the field. Overall, the Cancer Biomedicine program at UCL offers a rigorous, research-led training pathway for students aspiring to make impactful contributions to cancer science and medicine.